ENTITY

Apellis Pharmaceuticals (APLS US)

36
Analysis
Health CareUnited States
Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.
more
Publication Icon
No publications yet
Add Apellis Pharmaceuticals to your Watchlist to get alerts on new publications
Add to Watchlist
x